XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
OPERATING ACTIVITIES    
Net income including non-controlling interests $ 12,375 $ 10,054
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:    
Depreciation and amortization 2,400 2,468
Provision for doubtful accounts 1,206 1,061
Equity-based awards compensation expense 1,728 1,381
Deferred income taxes 2,118 (1,162)
Other 12 54
Changes in operating assets and liabilities:    
Increase in patient accounts receivable (4,898) (2,782)
Increase in accounts receivable - other (495) (849)
Increase in other assets (894) (1,238)
Increase in accounts payable and accrued expenses 274 7,389
Decrease in other liabilities (263) (845)
Net cash provided by operating activities 13,563 15,531
INVESTING ACTIVITIES    
Purchase of fixed assets (2,497) (1,404)
Purchase of redeemable non-controlling interest (2,053) (761)
Purchase of non-controlling interest (139) (246)
Proceeds on sale of fixed assets 59 0
Net cash used in investing activities (4,630) (2,411)
FINANCING ACTIVITIES    
Distributions to non-controlling interests, permanent and temporary equity (2,576) (2,208)
Proceeds from revolving line of credit 19,000 19,000
Payments on revolving line of credit (28,000) (31,000)
Payments to settle mandatorily redeemable non-controlling interests 0 (265)
Principal payments on notes payable (482) (823)
Other (5) 56
Net cash used in financing activities (12,063) (15,240)
Net decrease in cash and cash equivalents (3,130) (2,120)
Cash and cash equivalents - beginning of period 23,368 21,933
Cash and cash equivalents - end of period 20,238 19,813
Cash paid during the period for:    
Income taxes 313 2,941
Interest 343 526
Non-cash investing and financing transactions during the period:    
Purchase of business - seller financing portion $ 228 $ 150